Incyte to stop pancreatic cancer drug trial

(Reuters) - Incyte Corp said it would discontinue a late-stage trial of its pancreatic cancer drug, ruxolitinib, after the treatment's effectiveness was shown to be insufficient.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro